Ausgabe 10/2008
Inhalt (25 Artikel)
How much CT is needed in nuclear medicine
Chirayu Shah, James A. Patton, Martin P. Sandler
What oncologists need and require from nuclear medicine
M. A. Pantaleo, S. Fanti, M. Nannini, S. Boschi, C. Nanni, A. Maleddu, D. Rubello, G. Biasco
Detection of bone metastases in patients with prostate cancer by 18F fluorocholine and 18F fluoride PET–CT: a comparative study
Mohsen Beheshti, Reza Vali, Peter Waldenberger, Friedrich Fitz, Michael Nader, Wolfgang Loidl, Gabriele Broinger, Franz Stoiber, Ignac Foglman, Werner Langsteger
Diagnostic impact of 18F-FDG PET–CT evaluating solid pancreatic lesions versus endosonography, endoscopic retrograde cholangio-pancreatography with intraductal ultrasonography and abdominal ultrasound
Verena Schick, Christiane Franzius, Torsten Beyna, May Lin Oei, Jürgen Schnekenburger, Matthias Weckesser, Wolfram Domschke, Otmar Schober, Walter Heindel, Thorsten Pohle, Kai Uwe Juergens
Chemotherapy response assessment in stage IV melanoma patients—comparison of 18F-FDG-PET/CT, CT, brain MRI, and tumormarker S-100B
Klaus Strobel, Reinhard Dummer, Hans C. Steinert, Katrin Baumann Conzett, Karin Schad, Marisol Pérez Lago, Jan D. Soyka, P. Veit-Haibach, Burkhardt Seifert, V. Kalff
Concordance between results of somatostatin receptor scintigraphy with 111In-DOTA-DPhe1-Tyr3-octreotide and chromogranin A assay in patients with neuroendocrine tumours
Margarida Rodrigues, Michael Gabriel, Dirk Heute, Daniel Putzer, Andrea Griesmacher, Irene Virgolini
Correlation of [18F]FMISO autoradiography and pimonodazole immunohistochemistry in human head and neck carcinoma xenografts
Esther G. C. Troost, Peter Laverman, Mariëlle E. P. Philippens, Jasper Lok, Albert J. van der Kogel, Wim J. G. Oyen, Otto C. Boerman, Johannes H. A. M. Kaanders, Johan Bussink
Correction of oral contrast artifacts in CT-based attenuation correction of PET images using an automated segmentation algorithm
Alireza Ahmadian, Mohammad R. Ay, Javad H. Bidgoli, Saeed Sarkar, Habib Zaidi
Therapy options for treatment of hepatic malignancy
Teresa Szyszko, Alison Brooks, Paul Tait, Domenico Rubello, Adil AL-Nahhas
Selective hepatic arterial infusion of In-111-DTPA-Phe1-octreotide in neuroendocrine liver metastases
Georgios S. Limouris, Achilles Chatziioannou, Dimitrios Kontogeorgakos, Dimitrios Mourikis, Maria Lyra, Panagiotis Dimitriou, Anastasia Stavraka, Athanassios Gouliamos, Lambros Vlahos
188Re-loaded lipid nanocapsules as a promising radiopharmaceutical carrier for internal radiotherapy of malignant gliomas
E. Allard, F. Hindre, C. Passirani, L. Lemaire, N. Lepareur, N. Noiret, P. Menei, J-P. Benoit
Long-term evaluation of renal toxicity after peptide receptor radionuclide therapy with 90Y-DOTATOC and 177Lu-DOTATATE: the role of associated risk factors
Lisa Bodei, Marta Cremonesi, Mahila Ferrari, Monica Pacifici, Chiara M. Grana, Mirco Bartolomei, Silvia M. Baio, Maddalena Sansovini, Giovanni Paganelli
Quantitative PET imaging of Met-expressing human cancer xenografts with 89Zr-labelled monoclonal antibody DN30
Lars R. Perk, Marijke Stigter-van Walsum, Gerard W. M. Visser, Reina W. Kloet, Maria J. W. D. Vosjan, C. René Leemans, Giuseppe Giaccone, Raffaella Albano, Paolo M. Comoglio, Guus A. M. S. van Dongen
Macrocyclic chelator-coupled gastrin-based radiopharmaceuticals for targeting of gastrin receptor-expressing tumours
Stephan Good, Martin A. Walter, Beatrice Waser, Xuejuan Wang, Jan Müller-Brand, Martin P. Béhé, Jean-Claude Reubi, Helmut R. Maecke
Tetrafluorophenolate of HBED-CC: a versatile conjugation agent for 68Ga-labeled small recombinant antibodies
Matthias Eder, Björn Wängler, Stefan Knackmuss, Fabrice LeGall, Melvyn Little, Uwe Haberkorn, Walter Mier, Michael Eisenhut
Real-time in vivo monitoring of viable stem cells implanted on biocompatible scaffolds
Do Won Hwang, Sung June Jang, Yun Hui Kim, Hyun Joo Kim, In Kyong Shim, Jae Min Jeong, June-Key Chung, Myung Chul Lee, Seung Jin Lee, Seung U. Kim, Soonhag Kim, Dong Soo Lee
Non-invasive estimation of hepatic blood perfusion from H2 15O PET images using tissue-derived arterial and portal input functions
N. Kudomi, L. Slimani, M. J. Järvisalo, J. Kiss, R. Lautamäki, G. A. Naum, T. Savunen, J. Knuuti, H. Iida, P. Nuutila, P. Iozzo
Diagnostic accuracy of integrated FDG-PET/contrast-enhanced CT in staging ovarian cancer: comparison with enhanced CT
Kazuhiro Kitajima, Koji Murakami, Erena Yamasaki, Yasushi Kaji, Ichio Fukasawa, Noriyuki Inaba, Kazuro Sugimura
Long-term evaluation of renal toxicity after peptide receptor radionuclide therapy with 90Y-DOTATOC and 177Lu-DOTATATE: the role of associated risk factors
Lisa Bodei, Marta Cremonesi, Mahila Ferrari, Monica Pacifici, Chiara M. Grana, Mirco Bartolomei, Silvia M. Baio, Maddalena Sansovini, Giovanni Paganelli
Early myocardial engraftment of autologous CD34+ cells administered transcoronary via a physiological cell-delivery system
Piotr Musialek, Magdalena Kostkiewicz, R. Pawel Banys, Lukasz Tekieli, Marcin Majka, Mieczyslaw Pasowicz, Wieslawa Tracz
Six synchronous primary neoplasms detected by FDG-PET/CT
Miraude Adriaensen, Laura Schijf, Marie de Haas, Julia Huijbregts, Henk-Jan Baarslag, Gerald Staaks, John de Klerk
EANM procedure guideline for treatment of refractory metastatic bone pain
Lisa Bodei, Marnix Lam, Carlo Chiesa, Glenn Flux, Boudewijn Brans, Arturo Chiti, Francesco Giammarile
Guidelines for radioiodine therapy of differentiated thyroid cancer
M. Luster, S. E. Clarke, M. Dietlein, M. Lassmann, P. Lind, W. J. G. Oyen, J. Tennvall, E. Bombardieri